Medical glove maker Ansell is facing a shareholder class action investigation over a January earnings downgrade that sent the company’s share price plummeting.
An appeals court’s “radical” approach in the treatment of JobKeeper payments won’t be scrutinised by the High Court, which on Friday declined to hear an appeal by IAG in the second set of COVID-19 business interruption test cases.
A COVID-19 outbreak aboard the Ruby Princess that left 28 people dead was “something that was very likely to happen” and the cruise should never have sailed, a court heard as a class action trial against Carnival PLC kicked off.
The state of Victoria has brought criminal action against the DHHS over its handling of the hotel quarantine debacle in 2020 and wants to push off separate class action proceedings until the charges are heard.
The inquiry into former prime minister Scott Morrison’s appointment as shadow minister of five government portfolios is now seeking public submissions.
A class action against cruise operator Carnival PLC over the 2020 COVID-19 outbreak aboard the Ruby Princess will ask the High Court to hear a challenge to a decision that found a class action waiver for foreign passengers was not unfair.
The Full Federal Court has thrown out a decision that found foreign passengers could join a class action against cruise operator Carnival PLC over the 2020 COVID-19 outbreak aboard the Ruby Princess, finding a class action waiver was not unfair.
An appeals court has dismissed a challenge brought by a Snap Fitness franchisee to a ruling that found insurer Lloyd’s could rely on a conformity clause in its policy to deny business interruption coverage to the NSW gym for losses related to COVID-19.
The state of Victoria can’t duck class action claims that failures in its hotel quarantine program caused businesses to suffer losses when stage three and four restrictions were put in place during the state’s second wave of COVID-19 cases in 2020.
Two law firms that filed competing class actions against regenerative medicine company Mesoblast for allegedly misleading shareholders about its Remestemcel-L treatment for COVID-19 complications have agreed to join forces and sidestep a beauty parade.